Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Biopharma DealmakersBiopharma Dealmakers
VS
RocheRoche
Biopharma Dealmakers

Biopharma Dealmakers

4 Crinan Street, London, N1 9XW, GB

Last Update: 06/03/2026

View Profile
752/1000Fair

Biopharma Dealmakers – a Nature Research publication – showcases active partnering companies and their opportunities across the biopharma industry.

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:31
12-month incidents
0
Known data breaches
0
Attack type number
0
Roche

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH

Last Update: 09/09/2026

View Profile
Between 800 and 849
http://www.roche.com/
836/1000Good

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:103,689
Subsidiaries:51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Biopharma Dealmakers

Biopharma Dealmakers

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Roche

Roche

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biopharma Dealmakers in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2026.

Incidents

Incident History - Biopharma Dealmakers (X = Date, Y = Severity)

Biopharma Dealmakers cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Biopharma Dealmakers

Biopharma Dealmakers

Incidents
No explicit notable incidents reported.
Roche

Roche

Incidents
No explicit notable incidents reported.

FAQ

Between Biopharma Dealmakers company and Roche company, which one has the best AI Cybersecurity Score ?
Between Biopharma Dealmakers company and Roche company, which one has experienced more cyber incidents in the past ?
Between Biopharma Dealmakers company and Roche company, which one has experienced more cyber incidents this year ?
Between Biopharma Dealmakers company and Roche company, which one has experienced at least one ransomware attack ?
Between Biopharma Dealmakers company and Roche company, which one has experienced at least one data breach ?
Between Biopharma Dealmakers company and Roche company, which one has experienced at least one targeted cyberattack ?
Between Biopharma Dealmakers company and Roche company, which one has experienced at least one vulnerability ?
Between Biopharma Dealmakers company and Roche company, which one holds the most compliance certifications ?
Between Biopharma Dealmakers company and Roche company, which one holds the fewest compliance certifications ?
Between Biopharma Dealmakers company and Roche company, which one has the most subsidiaries ?
Between Biopharma Dealmakers company and Roche company, which one has the largest number of employees ?
Between Biopharma Dealmakers and Roche, which company holds both SOC 2 Type 1 certifications ?
Between Biopharma Dealmakers and Roche, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Biopharma Dealmakers or Roche ?
Which company is PCI DSS compliant - Biopharma Dealmakers or Roche ?
Between Biopharma Dealmakers and Roche, which company complies with HIPAA regulations for healthcare data ?
Between Biopharma Dealmakers and Roche, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-91201
SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-91200
SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-91199
SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5)
CVSS3
Base Score: 5.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.1
CVE-2026-91198
SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-91197
SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8